Natera, Inc.
NASDAQ:NTRAMedical - Diagnostics & Research
+$2.23 today
- Market cap
- $41.98B
- Beta
- 1.54
- P/E (TTM)
- -143.0
- EPS (TTM)
- -$1.60
Volume 1.96M
Average 1.41M
NTRA Change in Working Capital
Cash absorbed or released by changes in receivables, inventory, payables, and other operating balances.
Natera, Inc.NASDAQ: NTRA
Change in Working Capital · Q2 FY2026 · quarter ended Jun 2026
Change in working capital turns negative
Q2 FY2026 change in working capital was -$3.86M, compared with $30.8M a year earlier. Trailing-twelve-month change in working capital was -$50.85M.
Context
- Change in working capital amounted to 0.4% of revenue in FY2025, up 0.3 pp from a year earlier.
- Change in working capital increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly change in working capital holds near -$3.86M or moves back toward the trailing-twelve-month quarterly average of -$12.71M.
Sources:Cash FlowText generated from reported figures; not investment advice.
Change in Working Capital history
USD · from the cash flow
- Latest · FY2025
- 10.05M USD
- Year-over-year change
- +369.2%
| Period | Period end | Change in Working Capital | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 10.05M | +369.2% |
| FY2024 | 2024-12-31 | 2.14M | +104.5% |
| FY2023 | 2023-12-31 | (47.95M) | +42.3% |
| FY2022 | 2022-12-31 | (83.15M) | -82.3% |
| FY2021 | 2021-12-31 | (45.6M) | — |
Change in Working Capital vs competitors
How NTRA compares with its peers on the latest reported figures
- NTRA's LTM Jun 2026 change in working capital of $50.85M is the 2nd largest of the 8 companies compared; the peer median is $15.4M.
- Its year-over-year change of -168.0% is the lowest of 7, against a peer median of +54.3%.
- Change in working capital amounts to 1.9% of revenue for NTRA, versus a peer median of 10.7%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $91.08M | +315.2% | — | 28.4% | |
| LTM Jun 2026 | $50.85M | -168.0% | — | 1.9% | |
WGSGeneDx Holdings Corp. | LTM Jun 2026 | $48.41M | +82.7% | — | 10.7% |
BLLNBillionToOne, Inc. | LTM Jun 2026 | $44.82M | — | — | 11.3% |
| LTM Mar 2026 | $15.4M | -66.4% | -38.6% | 1.9% | |
| LTM Jun 2026 | $2.86M | +115.5% | -48.0% | 0.5% | |
| LTM Mar 2026 | $772K | -39.5% | — | 1354.4% | |
| LTM Mar 2026 | $666K | +25.9% | — | 1.0% | |
| Peer median (excluding NTRA) | $15.4M | +54.3% | -43.3% | 10.7% | |
Competitors are the stored peer set for NTRA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (471.72M) | (547.8M) | (434.8M) | (190.43M) | (208.16M) |
| Depreciation & Amortization | 11.25M | 16.7M | 24.1M | 30.97M | 43.48M |
| Deferred Income Tax | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 115.22M | 152.38M | 191.81M | 274.43M | 354.4M |
| Change in Working Capital | (45.6M) | (83.15M) | (47.95M) | 2.14M | 10.05M |
| Accounts Receivables | (43.51M) | (122.31M) | (33.9M) | (35.88M) | 20.75M |
| Inventory | (6.88M) | (8.5M) | (5.35M) | (3.99M) | (20.87M) |
| Accounts Payables | 19.22M | 5.46M | (15.46M) | 13.21M | 753K |
| Other Working Capital | (14.44M) | 42.2M | 6.76M | 28.79M | 9.41M |
| Other Non-Cash Items | 55.61M | 30.36M | 19.89M | 18.55M | 15.53M |
| Operating Cash Flow | (335.24M) | (431.5M) | (246.96M) | 135.66M | 215.3M |
| Capital Expenditures | (41.03M) | (47.7M) | (39.2M) | (66.42M) | (106.19M) |
| Acquisitions (Net) | 0 | 0 | 0 | 0 | (16.02M) |
| Purchases of Investments | (876.1M) | (86.95M) | (98.3M) | (124.68M) | 0 |
| Sales of Investments | 720.49M | 464.98M | 306M | 339.22M | 23M |
| Other Investing Activities | (8.56M) | 0 | 0 | (10.5M) | 0 |
| Investing Cash Flow | (205.19M) | 330.34M | 168.5M | 137.62M | (132.21M) |
| Debt Repayment | 0 | 30M | 0 | (82K) | 0 |
| Common Stock Issued | 576.19M | 452.64M | 254.46M | 30.29M | 47.46M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | 576.19M | 482.64M | 254.46M | 30.2M | 47.46M |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | 35.76M | 381.48M | 176M | 303.49M | 130.55M |
| Free Cash Flow | (376.27M) | (479.2M) | (286.15M) | 69.24M | 109.11M |
Natera, Inc.
NASDAQ:NTRA
Intrinsic Alpha fair value
Locked
Current Price
$289.50
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.